Copeptin and Acute Coronary Syndrome Without ST-segment Elevation

NACompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Chest Pain
Interventions
OTHER

Copeptin

"Patients with hyponatremia \< 135 mmol/L or troponin \> 1 μg/L are released study.~Blood sampling are taken for Troponine T, myoglobin, creatin kinase and copeptine analysis and 18-lead ECG was performed after 2, 4, 6 and 12 h.~Copeptin and myoglobin are measured at the end of the patients inclusion, after to be centrifugrd end frozen at -80°C at each time point.~The treatment of patients is not modified by the study. At 90 days, clinicals and paraclinicals events are collected"

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Association des Médecins des Urgences de Clermont-Ferrand

OTHER

collaborator

BRAHMS Biomarkers

UNKNOWN

collaborator

General Hospital Henri Mondor, Aurillac, France

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT01334645 - Copeptin and Acute Coronary Syndrome Without ST-segment Elevation | Biotech Hunter | Biotech Hunter